DK1025209T3 - Et attenueret japansk encephalitis-virus tilpasset til Vero-celle og en japansk encephalitis-vaccine - Google Patents

Et attenueret japansk encephalitis-virus tilpasset til Vero-celle og en japansk encephalitis-vaccine

Info

Publication number
DK1025209T3
DK1025209T3 DK98941885T DK98941885T DK1025209T3 DK 1025209 T3 DK1025209 T3 DK 1025209T3 DK 98941885 T DK98941885 T DK 98941885T DK 98941885 T DK98941885 T DK 98941885T DK 1025209 T3 DK1025209 T3 DK 1025209T3
Authority
DK
Denmark
Prior art keywords
japanese encephalitis
vero cell
attenuated
vaccine
virus adapted
Prior art date
Application number
DK98941885T
Other languages
English (en)
Inventor
Hyun Su Kim
Wang Don Yoo
Soo Ok Kim
Sung Hee Lee
Sang Bum Moon
Sun Pyo Hong
Yong Cheol Shin
Yong Ju Chung
Kenneth H Eckels
Bruce Innis
Joseph R Putnak
Leonard N Binn
Ashok K Srivastava
Doria R Dubois
Original Assignee
Cheil Jedang Corp
Us Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheil Jedang Corp, Us Army filed Critical Cheil Jedang Corp
Application granted granted Critical
Publication of DK1025209T3 publication Critical patent/DK1025209T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98941885T 1997-08-28 1998-08-25 Et attenueret japansk encephalitis-virus tilpasset til Vero-celle og en japansk encephalitis-vaccine DK1025209T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19970042001 1997-08-28
KR19970042002 1997-08-28
PCT/KR1998/000259 WO1999011762A1 (en) 1997-08-28 1998-08-25 An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine

Publications (1)

Publication Number Publication Date
DK1025209T3 true DK1025209T3 (da) 2007-06-25

Family

ID=26633032

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05014317.1T DK1604685T3 (da) 1997-08-28 1998-08-25 Et svækket japansk encephalitisvirus
DK98941885T DK1025209T3 (da) 1997-08-28 1998-08-25 Et attenueret japansk encephalitis-virus tilpasset til Vero-celle og en japansk encephalitis-vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK05014317.1T DK1604685T3 (da) 1997-08-28 1998-08-25 Et svækket japansk encephalitisvirus

Country Status (15)

Country Link
US (1) US6309650B1 (da)
EP (2) EP1025209B1 (da)
JP (1) JP4161017B2 (da)
KR (1) KR100314404B1 (da)
CN (1) CN1142271C (da)
AU (1) AU748730B2 (da)
CA (1) CA2301000C (da)
DE (2) DE122009000037I2 (da)
DK (2) DK1604685T3 (da)
ES (2) ES2382946T3 (da)
FR (1) FR09C0037I2 (da)
MY (1) MY129773A (da)
NL (1) NL300391I2 (da)
NZ (1) NZ503522A (da)
WO (1) WO1999011762A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083657A (ja) * 1998-07-13 2000-03-28 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスワクチン
AU743546B2 (en) 1998-10-05 2002-01-31 Research Foundation For Microbial Diseases Of Osaka University, The Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same
CA2650236C (en) * 1999-04-22 2016-01-12 United States Of America, As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
JP4751558B2 (ja) * 2000-04-07 2011-08-17 一般財団法人化学及血清療法研究所 日本脳炎不活化ワクチン及びその製造方法
BR0210628A (pt) * 2001-06-29 2004-08-10 Becton Dickinson Co Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula
JP2007068401A (ja) * 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
WO2005080556A2 (en) * 2004-02-23 2005-09-01 Crucell Holland B.V. Virus purification methods
CN100340596C (zh) * 2004-05-20 2007-10-03 佛山市顺德区汉达精密电子科技有限公司 回收聚碳酸酯/丙烯腈－丁二烯－苯乙烯共聚物及其回收方法
WO2006108707A1 (en) * 2005-04-11 2006-10-19 Crucell Holland B.V. Virus purification using ultrafiltration
CA2676775A1 (en) * 2007-01-31 2008-09-25 Sanofi Pasteur Biologics Co. Flavivirus vaccine vector against influenza virus
KR20160003301A (ko) * 2007-12-26 2016-01-08 기타사토 다이이치 산쿄 백신 가부시키가이샤 안정하게 장기간 보존할 수 있는 일본뇌염 백신의 제조방법 및 그 백신의 용도
KR101507822B1 (ko) 2008-06-04 2015-04-24 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법
JP5744517B2 (ja) * 2008-07-30 2015-07-08 久光製薬株式会社 マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法
WO2010137036A2 (en) * 2009-05-25 2010-12-02 Panacea Biotec Ltd Novel japanese encephalitis vaccine and method of manufacturing the same
KR101144993B1 (ko) * 2009-06-18 2012-06-27 대한민국 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원
PT3269386T (pt) 2011-12-06 2022-12-05 Valneva Austria Gmbh Compostos de alumínio para utilização em terapêuticas e vacinas
CN105744952A (zh) * 2013-09-14 2016-07-06 巴拉特生物技术国际有限公司 病毒疫苗及其制备方法
CN105695424B (zh) * 2015-04-01 2019-06-14 中国食品药品检定研究院 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗
EP4253403A3 (en) 2015-12-23 2023-12-27 Valneva Austria GmbH Zika virus purification
KR102405736B1 (ko) * 2016-01-15 2022-06-07 케이엠 바이올로직스 가부시키가이샤 고정화 바이러스 입자를 포함하는 백신
WO2017210215A1 (en) 2016-05-31 2017-12-07 The Government Of The United States Of America As Represented By The Secretary Of The Army Zika virus vaccine and methods of production
JP7301811B2 (ja) 2017-09-21 2023-07-03 ヴァルネヴァ エスイー 免疫原性チクングニアウイルスｃｈｉｋｖ－ｄｅｌｔａ ５ｎｓｐ３を含む医薬組成物を製造する方法
CA3081578A1 (en) 2017-11-03 2019-05-09 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
BR112020010466A2 (pt) 2017-11-30 2020-11-24 Takeda Vaccines, Inc. composições imunogênicas e vacinas contra zika, métodos de uso das mesmas
CN110684747B (zh) * 2018-07-06 2024-05-24 厦门大学 灭活及保存呼吸道合胞病毒的方法
EP3845639A4 (en) * 2018-08-27 2022-05-11 Mican Technologies Inc. METHOD FOR EVALUATING ANTI-INFECTIOUS DRUGS, VACCINES, ETC. USE OF IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS
EP3895729A1 (en) 2020-03-01 2021-10-20 Valneva Austria GmbH Cpg-adjuvanted sars-cov-2 virus vaccine
JP2023515908A (ja) 2020-03-01 2023-04-14 ヴァルネヴァ・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ＣｐＧアジュバント化ＳＡＲＳ－ＣｏＶ－２ウイルスワクチン
WO2021204825A2 (en) 2020-04-06 2021-10-14 Valneva Austria Gmbh INACTIVATED SARS-CoV-2 VIRUS VACCINE
WO2023148256A1 (en) 2022-02-02 2023-08-10 Valneva Austria Gmbh Inactivated sars-cov-2 virus vaccine
WO2024153686A1 (en) 2023-01-18 2024-07-25 Valneva Austria Gmbh Process for virus production in a bioreactor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2704258B2 (ja) * 1987-10-31 1998-01-26 日本臓器製薬株式会社 組み換えワクチニアウイルス
GB8821656D0 (en) * 1988-09-15 1988-10-12 Health Lab Service Board Pharmaceutical compositions for eliciting immunostimulant effect
JPH085803B2 (ja) * 1988-11-10 1996-01-24 武田薬品工業株式会社 日本脳炎ワクチンの製造法
EP0562136A1 (en) * 1992-03-24 1993-09-29 Division Of Microbiology, Kyoto Biken Laboratories, Inc. Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases
US6010894A (en) * 1997-06-13 2000-01-04 Research Development Foundation Method of screening for attenuating viruses

Also Published As

Publication number Publication date
NL300391I2 (nl) 2009-11-02
DE122009000037I2 (de) 2011-06-16
JP4161017B2 (ja) 2008-10-08
ES2281929T3 (es) 2007-10-01
WO1999011762A1 (en) 1999-03-11
KR100314404B1 (ko) 2002-10-12
NL300391I1 (nl) 2009-08-03
DE69837211T2 (de) 2007-12-06
CA2301000C (en) 2003-07-08
DE122009000037I1 (de) 2009-11-05
MY129773A (en) 2007-04-30
EP1604685A3 (en) 2006-07-05
NZ503522A (en) 2001-06-29
DE69837211D1 (de) 2007-04-12
US6309650B1 (en) 2001-10-30
CN1272879A (zh) 2000-11-08
KR19990023955A (ko) 1999-03-25
FR09C0037I1 (da) 2009-09-25
EP1025209B1 (en) 2007-02-28
EP1604685A2 (en) 2005-12-14
CN1142271C (zh) 2004-03-17
ES2382946T3 (es) 2012-06-14
CA2301000A1 (en) 1999-03-11
EP1025209A1 (en) 2000-08-09
FR09C0037I2 (fr) 2021-11-05
AU748730B2 (en) 2002-06-13
AU9004798A (en) 1999-03-22
JP2001514844A (ja) 2001-09-18
DK1604685T3 (da) 2012-06-18
EP1604685B1 (en) 2012-02-22

Similar Documents

Publication Publication Date Title
DK1025209T3 (da) Et attenueret japansk encephalitis-virus tilpasset til Vero-celle og en japansk encephalitis-vaccine
DE69731559D1 (de) Gesichts- und atemschutzsystem
NO20004104D0 (no) Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater
BR9609258A (pt) Vacinas contra hepatite c
DK0810877T3 (da) Hepatitis B-vaccine
EE200000348A (et) Inhalatsiooniseade ja -meetod
DE69214461D1 (de) Druckempfindliche membrane und verfahren dazu
DE69821408D1 (de) Multiplikationsverfahren und -vorrichtung
DE69504868D1 (de) Gasextraktionsvorrichtung
EP1037974A4 (en) TRUNCATED PROTEIN OF HEPATITIS C VIRUS NS5B AND RELATED METHODS OF IDENTIFYING ANTIVIRAL COMPOUNDS
DK1310167T3 (da) Forbedret celleudformning til et trawlsystem og fremgangsmåder
KR950700535A (ko) 가스검출장치
BR9403166A (pt) Catalisador de gás de escape
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
DE69826593D1 (de) Neospora Impstoff
FI922732A0 (fi) Ljudisolerad faeste foer en ultra- ljudomformare.
DE68908592D1 (de) Abgasrekombinator.
BR8902852A (pt) Sistema de recuperacao de metal precioso e aparelho de recuperacao de mercurio
KR980004483U (ko) 가스와 연막을 이용한 방범장치
SE9202575D0 (sv) Turbinbladsskydd (gasturbin)
SE9602714D0 (sv) A method of detecting potato virus (PVY) and other potato viruses in potato
PT841943E (pt) Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas
BR7700629U (pt) Dispositivo trava quedas
NO20003588D0 (no) En deteksjons og/eller kvantifiseringsmetode der TT virus
DK156090D0 (da) Fremgangsmaade og anlaeg til bekaempelse af svaevende mikrostoev, navnlig i dyrestalde